ArticleCureus2024
A Retrospective Analysis of the Effects of Pneumonia and Chronic Obstructive Pulmonary Disease on Patient Mortality in Southwest Missouri.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease. In this study, we aimed to explore the effects of COPD and pneumonia on the mortality rates among patients admitted to the Freeman Health System in Southwest Missouri, to provide a better idea of whether there is a correlation between the two and whether the presence of both adds to the mortality rates. Patient data were extracted from electronic medical records, focusing on patients with or without COPD and pneumonia diagnoses. Analyses revealed a statistical difference, with a p-value of <0.0001, in mortality rates between COPD patients with (P1) and without (P3) pneumonia, indicating that pneumonia did have an impact on COPD patients. However, pneumonia patients without COPD (P2) had a higher, but non-statistical difference in mortality rates compared to COPD patients with pneumonia (P1), with a p-value of 0.0806. These findings emphasize the severe influence of pneumonia in both COPD and non-COPD populations in the area, warranting further investigation and emphasizing the importance of timely and appropriate treatment. These results provide insights into the interplay between COPD and pneumonia in the geographic area, which may provide guidance in treatment decisions that may improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.